News from GenomeDx Biosciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 21, 2017, 08:00 ET GenomeDx's Decipher Cancer Classifier Tests and Genomic Database to be Featured in Multiple Presentations at ASTRO 2017

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that it will present results from three studies featuring...


Sep 14, 2017, 08:00 ET GenomeDx to Distribute Pathnostics' Guidance UGx Test for Urinary Tract Infection and Guidance PRx Test for Prostatitis

GenomeDx Biosciences, a leader in the field of urologic genomics, and Pathnostics, a provider of comprehensive and dynamic pathology services,...


Jun 29, 2017, 08:00 ET GenomeDx Announces New York State CLEP Approval of Decipher Prostate Cancer Tests

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced approval by the New York State Clinical Laboratory...


Jun 07, 2017, 08:00 ET Multiple Studies Further Validate the Importance of Decipher Post-Op in the Treatment of Prostate Cancer

GenomeDx Biosciences today announced results from three recent publications demonstrating the clinical validity of the Decipher® Prostate Cancer...


Jun 01, 2017, 08:00 ET GenomeDx's Decipher to be Featured in Multiple Presentations at ASCO 2017

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that it will present results from two studies featuring...


May 12, 2017, 08:00 ET GenomeDx and Color Collaborate to Further Advance Precision Medicine for Prostate Cancer Patients and their Families

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced a collaboration with Color to offer its Color Test, a...


May 11, 2017, 11:18 ET GenomeDx's Decipher GRID Aids in Development and Validation of Molecular Subtypes in Prostate Cancer that Predict Response to Hormone Therapy

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced that a genomic signature commonly used with breast cancer...


May 10, 2017, 08:00 ET GenomeDx Launches Decipher Bladder Cancer Classifier Following Publication of Study on Development, Validation of Molecular Subtyping in Muscle-Invasive Bladder Cancer Patients

GenomeDx Biosciences today announced the launch of its Decipher® Bladder Cancer Classifier (Decipher Bladder) following the publication of a study...


May 09, 2017, 08:00 ET GenomeDx Appoints Michael Rodriguez as Chief Financial Officer

GenomeDx Biosciences, a leader in the field of urologic cancer genomics, today announced the appointment of Michael Rodriguez as the company's...


May 04, 2017, 08:00 ET GenomeDx's Decipher GRID and Decipher Tests to be Featured in Multiple Abstracts at the 112th American Urological Association Annual Meeting

GenomeDx Biosciences today announced that seven abstracts featuring the company's Decipher® Genomics Resource Information Database (Decipher...


Apr 25, 2017, 08:00 ET GenomeDx's Decipher Post-Op Demonstrates Positive Impact on Physician, Patient Treatment Decisions in Multicenter Prospective Study

GenomeDx Biosciences today announced the publication of interim results from an ongoing prospective clinical study of the impact of the Decipher®...


Mar 24, 2017, 08:00 ET GenomeDx's Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at the 32nd Annual EAU Congress

GenomeDx Biosciences today announced that six abstracts featuring Decipher GRID® (Genomics Resource Information Database) and Decipher® Prostate...


Mar 02, 2017, 08:00 ET GenomeDx Biosciences Announces Initiation by Michigan Urological Surgery Improvement Collaborative (MUSIC) of Prospective, Randomized Clinical Study of Decipher

GenomeDx Biosciences today announced the initiation of a prospective, randomized controlled trial evaluating the utility of its Decipher® Prostate...


Feb 14, 2017, 08:00 ET GenomeDx's Decipher Prostate, GRID and Bladder Data to be Featured in Multiple Presentations at the 2017 Genitourinary Cancers Symposium

GenomeDx Biosciences today announced that oral and poster presentations featuring Decipher® Prostate Cancer Classifier tests, Genomics Resource...


Feb 01, 2017, 08:00 ET GenomeDx Announces Research Collaboration with Astellas to Identify Genomic Drivers of Patient Response to XTANDI® (enzalutamide) Capsules

GenomeDx Biosciences today announced that it has entered into a research collaboration with Astellas, a leading global pharmaceutical company, to...


Jan 25, 2017, 08:00 ET GenomeDx's Decipher Biopsy Demonstrates Ability to Predict Metastasis After Radiation and Androgen Deprivation Therapy in Prostate Cancer Patients

GenomeDx Biosciences today announced the first study that demonstrates the ability of the Decipher® Prostate Cancer Classifier Biopsy Test...


Nov 29, 2016, 08:00 ET GenomeDx's Decipher Prostate and Bladder Data to be Featured in Multiple Presentations at 17th Annual Meeting of the Society of Urologic Oncology

GenomeDx Biosciences today announced that ten presentations featuring Decipher® Prostate and Bladder data will be presented at the 17th...


Oct 19, 2016, 08:00 ET GenomeDx's Decipher GRID Aids in Development and Validation of the First Molecular Signature to Predict Response to Radiotherapy in Prostate Cancer

GenomeDx Biosciences today announced that gene expression profiles in the company's Decipher Genomics Resource Information Database (Decipher...


Oct 04, 2016, 08:00 ET GenomeDx and Bostwick Laboratories Announce Marketing Agreement for Decipher Prostate Cancer Classifier Test

 GenomeDx Biosciences and Bostwick Laboratories, Inc. today announced that Bostwick has entered into a marketing partnership agreement with...


Sep 29, 2016, 08:00 ET GenomeDx Launches Expanded GRID Tumor Profiling to Provide Enhanced Genomic Understanding of Patients' Prostate Cancer

 GenomeDx Biosciences today announced that it has launched an expanded version of its Decipher GRID® Tumor RNA Expression Profile, a...


Sep 28, 2016, 08:00 ET GenomeDx and SouthGenetics Announce Strategic Agreement for Latin America Commercialization

 GenomeDx Biosciences and SouthGenetics Inc. today announced that they have signed a strategic agreement to bring GenomeDx's Decipher®...


Sep 22, 2016, 08:00 ET GenomeDx's Decipher GRID and Decipher Tests to be Featured in Multiple Presentations at ASTRO 2016

 GenomeDx Biosciences today announced that eight presentations featuring Decipher Genomics Resource Information Database (Decipher GRID®)...


Sep 13, 2016, 08:00 ET GenomeDx Adds Multiple Leading Cancer Centers to Its Proprietary Genomics Resource Information Database Platform (Decipher GRID)

GenomeDx Biosciences today announced that it has expanded access to its Decipher Genomics Resource Information Database (Decipher GRID®) to a...


Sep 06, 2016, 08:00 ET Prospective Study Shows GenomeDx's Decipher Cancer Classifier Significantly Reclassifies Tumor Aggressiveness

GenomeDx Biosciences today announced the publication of the first prospective validation study for its Decipher® Prostate Cancer Classifier...


Jul 06, 2016, 08:00 ET GenomeDx Biosciences Receives Accreditation from College of American Pathologists

GenomeDx Biosciences, a leading provider of genomic solutions, today announced that it has received Laboratory Accreditation from the College of...